HBEGF and neoplasm: We also identified pairs of IL‐10 and IL‐10RA/B, JAG2 and NOTCH1/2/4, HBEGF and CD9 that may suppress T cell response or promote tumour cell growth or drug resistance (Figure 5A).47, 48, 49